Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease

Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation

(2016) F. Rossi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Specific types of alcoholic beverage consumption and risk of type 2 diabetes: A systematic review and meta-analysis

(2016) Jin Huang et al.   Journal of Diabetes Investigation

Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation

(2016) Aditya Ambade et al.   Scientific Reports

Cannabis sativa: The Plant of the Thousand and One Molecules

(2016) Christelle M. Andre et al.   Frontiers in Plant Science

Marijuana use and inpatient outcomes among hospitalized patients: analysis of the nationwide inpatient sample database

(2016) Neomi Vin-Raviv et al.   Cancer Medicine

Aging and liver disease

(2015) In Hee Kim et al.   CURRENT OPINION IN GASTROENTEROLOGY

Brief Report

(2015) Omayma Alshaarawy et al.   EPIDEMIOLOGY

Gut–Liver Axis in Alcoholic Liver Disease

(2015) Gyongyi Szabo   GASTROENTEROLOGY

The mechanism by which moderate alcohol consumption influences coronary heart disease

(2015) Marc J Mathews et al.   Nutrition Journal

Association Between Cannabis Use and the Risk of Bladder Cancer: Results From the California Men's Health Study

(2015) Anil A. Thomas et al.   UROLOGY

Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy

(2014) Lili Yang et al.   FREE RADICAL BIOLOGY AND MEDICINE

Moderate Alcohol Induces Stress Proteins HSF1 and hsp70 and Inhibits Proinflammatory Cytokines Resulting in Endotoxin Tolerance

(2014) Sujatha Muralidharan et al.   JOURNAL OF IMMUNOLOGY

Autophagy: Emerging roles in lipid homeostasis and metabolic control

(2012) Patricia Christian et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy

(2011) D Vara et al.   CELL DEATH AND DIFFERENTIATION

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts

(2011) Jonel Trebicka et al.   LIVER INTERNATIONAL

Cannabis use in young people: The risk for schizophrenia

(2011) Paola Casadio et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Role of Cannabinoids in the Development of Fatty Liver (Steatosis)

(2010) Vishnudutt Purohit et al.   AAPS Journal

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

(2010) Michelle DallaPiazza et al.   BMC INFECTIOUS DISEASES

Endocannabinoids in liver disease

(2010) Joseph Tam et al.   HEPATOLOGY

Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors

(2010) Bogna Ignatowska-Jankowska et al.   NEUROSCIENCE LETTERS

Hepatitis C Virus Induces the Cannabinoid Receptor 1

(2010) David van der Poorten et al.   PLoS One

Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis

(2010) J. R. Maxwell et al.   RHEUMATOLOGY

Are adolescents who moderate their cannabis use at lower risk of later regular and dependent cannabis use?

(2009) Wendy Swift et al.   ADDICTION

Alcoholic liver disease

(2009) Robert S. O'Shea et al.   HEPATOLOGY

Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells

(2009) María Salazar et al.   JOURNAL OF CLINICAL INVESTIGATION

Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

(2008) Won-il Jeong et al.   Cell Metabolism

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

(2008) Asmaa Ibrahim Gomaa et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY

Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors

(2007) Giovanna Fattovich et al.   JOURNAL OF HEPATOLOGY